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Abstract: The title compound (3) is synthesized by the nucleophilic substitution of  
4-chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline 2 with 4-amino acetophenone in  
n-butanol. Newly prepared imiquimod derivative (3) is characterized by IR, NMR and 
mass spectral data. 
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Introduction 
The quinoline scaffold is prevalent in a variety of pharmacologically active synthetic and natural 
compounds [1]. Imidazoquinoline is a double cyclic organic molecule; its derivatives and compounds 
are synthetic immunomodulatory drugs that act by binding toll-like receptors 7 and 8 (TLR7/TLR8) on 
dendritic cells [2,3]. Imidazoquinoline amine compounds are now known to be the first small low-
molecular-weight immune response modifiers that function through the TLR receptors have potent 
anti-viral, anti-tumour, non-xanthine adenosine antagonist properties. The biological activity 
associated with imiquimod has been attributed to its induction of interferon (IFN)-alpha [4–7]. The 
various biological importance of imiquimod has prompted us to design and synthesize new structural 
analogue of imiquimod.  
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Results and Discussion 
Several methods are known in the art of making 1H-imidazo[4,5-c]quinoline 4-amines and its 
derivatives, including Imiquimod. Literature revealed that amination of 4-chloro-1-isobutyl-1H-
imidazo[4,5-c]quinoline can be carried out by three ways; The first is by nucleophilic substitution of a 
leaving group, the second is by reacting 1-isobutyl-1H-imidazo[4,5-c]quinoline-N-oxide with 
ammonium hydroxide or ammonium salts in presence of tosyl chloride at 0–5 °C and third is by 
reacting 1-isobutyl-1H-imidazo[4,5-c]quinoline-N-oxide with benzoyl chloride [8]. 
The title compound, 1-{4-[(1-isobutyl-1H-imidazo[4,5-c]quinolin-4-yl)amino]phenyl}ethanone 3 
was prepared by the amination of 4-chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline 2 with 4-amino 
acetophenone in n-butanol by using the first method, i.e., nucleophilic substitution reaction. Starting 
material 4-chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline 2 was in turn synthesized by using literature 
method [9]. The product 3 was well characterized by using NMR, 13C-NMR, IR and mass spectral data. 























1. H2O2 / CH3CO2H
2. POCl 3 / DMF
1 2 3
 
The 1H NMR spectrum of 1-{4-[(1-isobutyl-1H-imidazo[4,5-c]quinolin-4-yl)amino]phenyl}ethanone 3 
showed doublet and septet resonating at δ 0.94 (J = 6.5 Hz) and 2.24 (J = 6.7 Hz) which was assigned 
to the six methyl protons and one methine proton of isopropyl moiety. A doublet appeared at δ 4.48  
(J = 7.4 Hz) was due to the methylene protons. The methyl protons of acetyl group appeared as  
a singlet at δ 2.53 ppm. The triplet located at δ 7.61 (J = 7.6 Hz) indicated one aromatic H-7 proton 
and another triplet at δ 7.48 (J = 7.5 Hz) indicated the nearest H-8 aromatic proton of quinoline 
moeity. A multiplet observed in the region δ 7.90–8.44 ppm for 6 aromatic protons present in the 
compound. The singlet located at δ 9.68 ppm indicated the presence of one NH proton. Another singlet 
appeared at δ 8.36 ppm indicated the proton of CH=N group. The IR spectrum showed an absorption band 
at 1668 cm−1 due to carbonyl stretching. The absorption band at 3,390 cm−1 is due to –NH stretching. 
Furthermore, the structure was also supported by the mass spectrum of compound 3 which showed  
a molecular ion peak at m/z 359 (M++1). Elemental analysis and 13C-NMR spectrum also gave 
satisfactory results for the title compound. 
Experimental 
Melting point was taken in open capillary tube and was uncorrected. The purity of the compound 
was confirmed by thin layer chromatography using Merck silica gel 60 F254 coated aluminium plates. 
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IR spectrum was recorded on Shimadzu-FTIR Infrared spectrometer in KBr (νmax in cm−1). 1H-NMR 
(400 MHz) spectrum was recorded on a Bruker AMX 400 spectrometer, with 5 mm PABBO BB-1H 
TUBES and 13C-NMR (100 MHz) spectrum was recorded for approximately 0.03 M solutions in 
DMSO-d6 at 100 MHz with TMS as internal standard. LCMS was obtained using Agilent 1200 series 
LC and Micromass zQ spectrometer. Elemental analysis was carried out by using VARIO EL-III 
(Elementar Analysensysteme GmBH). 
4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline 2 (1 mmol, 0.259 g) was dissolved in n-butanol 
(20 mL) and then p-amino acetophenone (1 mmol, 0.135 g) was added. Reaction mixture was refluxed 
for 6 h. The contents of the flask was concentrated to half of the volume and cooled. The product 
obtained was filtered, washed with water, dried and recrystallized from ethanol to give the pale yellow 
colored solid. Yield was 0.302 g (84%). 
Melting point: 100–102 °C.  
LCMS: m/z = 359 (M++1). 
IR (KBr): νmax (cm−1), 3392 (N-H), 2960 (C-H), 1668 (C=O), 1531 (C=C). 
1H-NMR (400 MHz, DMSO-d6): δ ppm, 0.94 (d, 6H, CH3×2, J = 6.5 Hz), 2.24 (sep, 1H, CH,  
J = 6.7 Hz), 2.53 (s, 3H, COCH3), 4.48 (d, 2H, CH2, J = 7.4 Hz), 7.61 (t, 1H, H-7, J = 7.6 Hz), 7.48 (t, 
1H, H-8, J = 7.5 Hz), 7.90–8.44 (m, 6H, Ar-H), 8.36 (s, 1H, CH=N), 9.68 (s, 1H, NH). 
13C-NMR (100 MHz, DMSO-d6): δ ppm, 19.8 (CH3), 26.8 (COCH3), 28.9 (CH), 54.0 (CH2), 116.2, 
118.6, 121.0, 123.9, 127.7, 128.3, 129.2, 129.8, 130.2, 132.6, 144.0, 144.4, 146.1, 147.6 (Ar-C’s), 
196.7 (C=O). 
Elemental analysis: Calculated for C22H22N4O, C, 73.72%; H, 6.19%; N, 15.63%. Found: C, 73.67%; 
H, 6.15%; N, 15.57%. 
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